In recent years, many clinical laboratories have incorporated sodium polyanethol sulfonate (SPS) into the medium used in their blood culture systems. The question of the toxicity of SPS to certain organisms has been raised and has resulted in the use of various concentrations of this substance in blood culture systems. As a result of the wide use of SPS in the past few years, the controversy as to its toxicity can be heard at any meeting of clinical microbiologists. To the best of our knowledge, however, there are only nine reports that have appeared in the literature concerning toxicity studies of SPS and bacteria. Unfortunately, all of these reports except for two either deal with artificially inoculated blood culture systems or do not deal with blood cultures at all. The two that deal with actual blood cultures (2, 8) indicate that the SPS produces superior results in a blood culture system (2); however, in a case involving one organism, Streptobacillus moniliformis (8), recovery was not accomplished from broth containing SPS. All of the remaining papers (1, (3) (4) (5) (6) (7) 9 ) deal with artificial situations and, thus, the actual toxicity of SPS in clinical blood cultures using a hypertonic medium has not been established. The purpose of this report is to determine the toxic effects of SPS on a wide spectrum of organisms encountered in clinical blood cultures by using hypertonic medium and various concehtrations of SPS.
By using parallel culture techniques, the recovery rates of a wide spectrum of organisms encountered in hypertonic clinical blood cultures was determined from four different blood culture bottles. Each bottle was identical except for the amount of sodium polyanethol sulfonate (SPS) present. Flasks A, B, C, and D contained SPS in final concentrations of 0.025, 0.05, 0.075, and 0%, respectively. Of 144 patients found to have clinically relevant organisms in their blood cultures, 127 had positive A flasks, 144 had positive B flasks, 140 had positive C flasks, and 110 had positive D flasks. There was no significant difference in the time required to obtain organism recovery from the A, B, or C flasks; however, the time required to obtain organism recovery from the D flask was considerably longer, ranging up to 5 days in many cases. Of the various organisms recovered, 3 of 7 strains of anaerobic streptococci and 1 of 28 strains of Streptococcus pneumoniae appeared to be inhibited by SPS when the concentration was 0.075%. In no case was an organism recovered from either the A or D flask but not from the B flask, indicating that a concentration of 0.05% SPS in hypertonic media does not inhibit the growth of a wide spectrum of organisms in clinical blood cultures.
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MATERIALS AND METHODS
For each blood culture requested, four blood culture flasks were each inoculated with 5-ml volumes of 20-ml blood specimens collected in syringes and inoculated at the patients' bedside. The four flasks were labeled A, B, C, and D and were identical in every respect except for the concentration of SPS. Each flask was glass with a rubber-diaphramed screwtop closure and each flask contained 45 ml of tryptic soy broth (Difco) made hypertonic by the addition of sucrose in a final concentration of 10%. Flasks A, B, and C contained SPS in final concentrations of 0.025, 0.05, and 0.075%, respectively; flask D contained no SPS and was used as a control flask.
All flasks were incubated at 35 C for 18 to 24 h at which time each flask was subcultured to two chocolate agar plates. One plate was incubated under a 10% carbon dioxide atmosphere, whereas the other was incubated in an anaerobic jar using a GasPak (BBL). This subculture procedure was repeated again on all flasks that failed to indicate growth from the 24-h subculture at 48 h and again after 72 h of incubation. To be included in this study, all four flasks had to receive the proper inoculum and had to complete the J. CLIN. MICROBIOL. 
